The UK’s chief Brexit negotiator, minister David Davis will fight to keep the EuropeanMedicinesAgency in London, despite the country leaving the EU. The Financial Times has reported that the ...
The European Commission (EC) will decide in approximately two months. Last month, Novartis released new data from the ALITHIOS open-label extension study. Data show first-line Kesimpta (ofatumumab ...
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (" NurExone " or the " Company "), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce ...
Results that may be inaccessible to you are currently showing.